Cart
sales@molnova.com
Fz7-21 TFA (2247635-23-8 free base)
CAS No.
Fz7-21 TFA (2247635-23-8 free base) ( (Ac)-LPSDDLEFWCHVMY-NH2 TFA )
Catalog No. M29961 CAS No.
Fz7-21 TFA ((Ac)-LPSDDLEFWCHVMY-NH2 TFA), a peptide antagonist of Frizzled 7 (FZD 7) receptors, selectively binds to FZD7 CRD subclass. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameFz7-21 TFA (2247635-23-8 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionFz7-21 TFA ((Ac)-LPSDDLEFWCHVMY-NH2 TFA), a peptide antagonist of Frizzled 7 (FZD 7) receptors, selectively binds to FZD7 CRD subclass. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively.
-
DescriptionFz7-21 TFA ((Ac)-LPSDDLEFWCHVMY-NH2 TFA), a peptide antagonist of Frizzled 7 (FZD 7) receptors, selectively binds to FZD7 CRD subclass. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively.
-
Synonyms(Ac)-LPSDDLEFWCHVMY-NH2 TFA
-
PathwayOthers
-
TargetOther Targets
-
RecptorEC50: 58 nM (human FZD7 CRD), 34 nM (mouse FZD7 CRD)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight1910.1
-
Molecular FormulaC85H115N18F3O25S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Nile AH, et al. Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells. Nat Chem Biol. 2018 Sep;14(9):902.
molnova catalog
related products
-
Diperodon hydrochlor...
Diperodon is a local anaesthetics, by the action of hydrolazes in blood serum is decomposed.
-
2-Isopropoxy-2-Pheny...
2-Isopropoxy-2-Phenylacetophenone is a natural compound.
-
Glyasperin C
Glyasperin C acts as a partial estrogen antagonist, it shows tyrosinase inhibitory activity (IC (50) = 0.13 +/- 0.01 microg/mL), it could be a promising candidate in the design of skin-whitening agents. Glyasperin C shows potent anti-vancomycin-resistant Enterococci effects (MIC 1.9 × 10-5-4.5 × 10-5 M for E. faecium and E. faecalis).
